| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,841 |
9,637 |
$587K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,475 |
5,417 |
$257K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
4,735 |
4,586 |
$245K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,784 |
1,751 |
$160K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
2,685 |
2,649 |
$120K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,376 |
2,187 |
$88K |
| 90686 |
|
5,590 |
5,533 |
$51K |
| 99173 |
|
5,274 |
5,190 |
$51K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
748 |
735 |
$45K |
| 92551 |
|
3,548 |
3,479 |
$45K |
| 90670 |
|
3,712 |
3,617 |
$45K |
| 90648 |
|
4,122 |
4,025 |
$38K |
| 90723 |
|
3,044 |
2,956 |
$33K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,921 |
1,700 |
$29K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
342 |
340 |
$25K |
| 90688 |
|
1,450 |
1,441 |
$20K |
| 90681 |
|
1,756 |
1,693 |
$20K |
| 99499 |
|
621 |
614 |
$16K |
| 96127 |
|
2,079 |
2,057 |
$16K |
| 90633 |
|
1,831 |
1,791 |
$16K |
| 99177 |
|
697 |
686 |
$15K |
| 96161 |
|
2,706 |
2,609 |
$13K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
60 |
60 |
$12K |
| 90651 |
|
1,143 |
1,131 |
$11K |
| 90734 |
|
744 |
736 |
$7K |
| 3008F |
|
706 |
705 |
$7K |
| 90716 |
|
828 |
798 |
$6K |
| 90707 |
|
815 |
784 |
$6K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
397 |
381 |
$5K |
| 0111A |
|
76 |
76 |
$5K |
| 90700 |
|
716 |
709 |
$5K |
| 69210 |
|
89 |
89 |
$5K |
| 90620 |
|
404 |
403 |
$4K |
| 90710 |
|
534 |
531 |
$4K |
| 90696 |
|
533 |
530 |
$4K |
| 90461 |
|
120 |
91 |
$3K |
| 90671 |
|
218 |
218 |
$3K |
| 90715 |
|
345 |
339 |
$3K |
| 85018 |
|
426 |
419 |
$3K |
| 0112A |
|
27 |
27 |
$2K |
| 90677 |
|
130 |
130 |
$2K |
| 99188 |
|
59 |
56 |
$2K |
| 0002A |
|
18 |
18 |
$1K |
| 0072A |
|
16 |
16 |
$1K |
| 0144A |
|
13 |
13 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
85 |
85 |
$1K |
| 0001A |
|
26 |
26 |
$593.53 |
| 94760 |
|
288 |
283 |
$455.90 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
48 |
47 |
$420.36 |
| 99000 |
|
165 |
160 |
$37.56 |
| 36416 |
|
191 |
187 |
$28.14 |